Reven Pharmaceuticals logo — Diligently pursuing scientific innovation to exponentially i...

Reven Pharmaceuticals

Diligently pursuing scientific innovation to exponentially improve health and well-being.

Founded 1999 United States Westminster, United States 14 employees Series D Biotechnology, Health Care +2

General Information

Company Name Reven Pharmaceuticals
Founded Year 1999
Location United States Westminster, United States
Founders / Decision Makers
Team member
Employees 14
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Series D
Social

BounceWatch is an independent company data service, not affiliated with Reven Pharmaceuticals. To contact Reven Pharmaceuticals, visit reven.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Reven Pharmaceuticals

Reven Pharmaceuticals is a privately-held clinical-stage biopharmaceutical company founded in 1999. With a focus on scientific innovation, the company operates within the Biotechnology, Health Care, Health and Wellness, and Pharmaceutical industries. Their dedication to improving health and well-being is encapsulated in their slogan, "Diligently pursuing scientific innovation to exponentially improve health and well-being." The most recent milestone for Reven Pharmaceuticals was their Series D investment in January 2019, representing a key moment in the company's growth trajectory. This development signifies a pivotal stage in Reven Pharmaceuticals' journey, underlining their potential for scalability and impact within the biopharmaceutical sector.

Taxonomy: biopharmaceuticals, clinical-stage, vascular treatments, metabolic treatments, health innovation, therapeutics, scientific research, critical limb ischemia, peripheral arterial disease, coronary artery disease, endothelial dysfunction, drug development, clinical trials, medical advancements

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series D Undisclosed -
01 Jan 2019
Series C Undisclosed -
01 Jan 2017
Series B Undisclosed -
01 Jan 2016
Venture Series Unknown Undisclosed -
19 Feb 2015
Series A Undisclosed -
01 Jan 2014

Reven Pharmaceuticals Alternatives & Competitors

Reven Pharmaceuticals vs

Pioneering medical advancements to improve renal and vascular health through innovative tissue remod...

Post-IPO Equity
Biotechnology, Pharmaceutical
Reven Pharmaceuticals vs

Cardiovascular Systems, Inc. (CSI) is committed to providing innovative solutions for the revascular...

Post-IPO Debt
343 employees
Biotechnology, Health Care
Reven Pharmaceuticals vs

Pioneering solutions for autoimmune and gastrointestinal health with a promising treatment for celia...

Debt Financing
1 employees
Biotechnology, Health and Wellness

FAQ About Reven Pharmaceuticals

Diligently pursuing scientific innovation to exponentially improve health and well-being.
Reven Pharmaceuticals was founded in 1999.
Reven Pharmaceuticals is headquartered in Westminster, United States.
Reven Pharmaceuticals operates in Biotechnology, Health Care, Health and Wellness and Pharmaceutical. Its work centres on biopharmaceuticals, clinical-stage, vascular treatments and metabolic treatments.
Reven Pharmaceuticals has approximately 14 employees.
Reven Pharmaceuticals has completed 5 funding rounds. The latest funding stage is Series D.
Top alternatives and competitors to Reven Pharmaceuticals include Proteon Therapeutics, Cardiovascular Systems, Inc., Alvine Pharmaceuticals, Athersys, Antiva Biosciences, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Reven Pharmaceuticals and Proteon Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Reven Pharmaceuticals, https://bouncewatch.com/company/reven-pharmaceuticals, updated 28 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes